Imperial Pacific Internationalの収益YQ/Q
Imperial Pacific Internationalの収益YQ/Qは何ですか。
Imperial Pacific International Holdings Limitedの収益YQ/Qは-97.45%です。
収益YQ/Qの定義は何ですか。
四半期収益成長率、前年比は、前年同期の業績と比較して、売上高の増加率がパーセンテージとして表されています。
Quaterly revenue growth is the amount by which revenue exceeds the revenue in a previous quarter. It is beneficial to look at a company's quarterly financials to identify how the company is performing over time not just during the current period. The usage of year over year comparison is advantageous in removing seasonalities in reporting the quarterly revenue growth and observing longterm trends.
HKSEのセクタConsumer Discretionaryにおける収益YQ/Qの企業と比べるImperial Pacific International
Imperial Pacific Internationalは何をしますか。
Imperial Pacific International Holdings Limited, an investment holding company, engages in the gaming and resort business in the Island of Saipan, Commonwealth of the Northern Mariana Islands. The company is involved in the development and operation of a hotel and a casino resort. It also provides marketing and promotion, management, and consultancy services; and holds leasehold land, aircraft, and yachts. The company was formerly known as First Natural Foods Holdings Limited and changed its name to Imperial Pacific International Holdings Limited in May 2014. Imperial Pacific International Holdings Limited was incorporated in 2001 and is based in Wan Chai, Hong Kong. Imperial Pacific International Holdings Limited is a subsidiary of Inventive Star Limited.
Imperial Pacific Internationalと類似の収益yq/q
- Filatex Fashionsの収益YQ/Qは-97.66%です。
- Fremont Petroleumの収益YQ/Qは-97.59%です。
- Richly Field China Developmentの収益YQ/Qは-97.58%です。
- Generex Biotechnologyの収益YQ/Qは-97.56%です。
- Spruce Ridge Resourcesの収益YQ/Qは-97.50%です。
- Epigenomics AGの収益YQ/Qは-97.50%です。
- Imperial Pacific Internationalの収益YQ/Qは-97.45%です。
- Guardion Health Sciences Incの収益YQ/Qは-97.39%です。
- Shenyang Public Utilityの収益YQ/Qは-97.37%です。
- Golden Tobaccoの収益YQ/Qは-97.35%です。
- Radaan Mediaworks Indiaの収益YQ/Qは-97.32%です。
- Premium Incomeの収益YQ/Qは-97.28%です。
- Paradigm Biopharmaceuticalsの収益YQ/Qは-97.20%です。